Testing resistant potato starch to reduce resistant gut bacteria
Part of Infections clinical trials.
This study tests whether a special type of starch (resistant potato starch) can help reduce the amount of antibiotic-resistant bacteria in your gut. If it works, it might lower your risk of infections from these bacteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have tested positive for at least one of these bacteria in your gut: C. difficile, MRSA, VRE, or multi-drug resistant Enterobacteriaceae (MDRE).
- You are not currently hospitalized and are able to come for outpatient visits.
- You are not allergic to any ingredients in the study product (potato starch) or placebo.
- You do not have a severe stomach or intestinal condition that would be worsened by high fiber, such as bowel obstruction, severe inflammatory bowel disease, or a history of diverticulitis.
- You are not taking certain immune-suppressing medications, and have not had an organ transplant or certain types of chemotherapy.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You have not used probiotics or fiber supplements in the past 30 days, and you are not currently taking antibiotics for an active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a fecal transplant (FMT) can remove certain antibiotic-resistant bacteria from your gut. It might help people who carry superbugs like CPE or VRE but aren't currently on antibiotics.
This study tests a special type of cassava starch (a common food ingredient) to see if it helps control blood sugar and acts as a fiber that supports gut health. If you are a healthy adult, you may be able to participate and contribute to research on everyday foods.
This study tests whether adding a daily fiber supplement can improve health in people with heart failure and type 2 diabetes. Participants take the supplement for several weeks to see if it helps manage symptoms and blood sugar.
This Phase 2 study tests whether an investigational treatment can help clear or reduce antibiotic-resistant bacteria living in the gut. It may help prevent these germs from causing future infections by targeting specific resistant bacteria found on stool or rectal swabs.
This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.
This study is testing whether a special type of starch (resistant potato starch) can help people with cirrhosis who have had episodes of confusion from liver problems. It may help by changing the bacteria in your gut, which could reduce the risk of future confusion episodes.
Hear when a new Carbapenem-Resistant Enterobacteriaceae trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.